We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
LPIXEL Inc., a leader in image analysis and processing technology in life science and medical research has announced the initiation of the artificial intelligence (AI) system development for cell evaluation with Astellas Pharma Inc.